Tamar Feuerstein

Blinatumomab as a bridge to further therapy in cases of overwhelming toxicity in pediatric B‐cell precursor acute lymphoblastic leukemia: Report from the Israeli Study Group of Childhood Leukemia

A. Gural, R. Elhasid, S. Izraeli, 2019, Pediatric blood & cancer.

An Extensive Quality Control and Quality Assurance (QC/QA) Program Significantly Improves Inter-Laboratory Concordance Rates of Flow-Cytometric Minimal Residual Disease Assessment in Acute Lymphoblastic Leukemia: An I-BFM-FLOW-Network Report

E. Mejstrikova, O. Hrusak, M. Schrappe, 2021, Cancers.

Modulating ALA-PDT efficacy of mutlidrug resistant MCF-7 breast cancer cells using ALA prodrug.

Z. Malik, A. Nudelman, A. Rephaeli, 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

Pediatric myelodysplastic syndrome with inflammatory manifestations: Diagnosis, genetics, treatment, and outcome

S. Izraeli, H. Tamary, I. Geron, 2021, Pediatric blood & cancer.

Early‐life liver cirrhosis and variable clinical presentation in telomere disease

B. Yerushalmi, G. Ling, Y. Kodman, 2022, Acta paediatrica.

International cooperative study identifies treatment strategy in childhood ambiguous lineage leukemia.

E. Mejstrikova, O. Hrusak, M. Schrappe, 2018, Blood.

CD371 cell surface expression: a unique feature of DUX4-rearranged acute lymphoblastic leukemia

N. Popitsch, E. Mejstrikova, O. Hrusak, 2019, Haematologica.

The centrality of PBGD expression levels on ALA-PDT efficacy

Z. Malik, Tamar Feuerstein, A. Schauder, 2011, Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology.

FCM marker importance for MRD assessment in T‐cell acute lymphoblastic leukemia: An AIEOP‐BFM‐ALL‐FLOW study group report

O. Hrusak, B. Buldini, M. Dworzak, 2023, Cytometry. Part A : the journal of the International Society for Analytical Cytology.